Selected article for: "antiviral stockpile and co morbidity impose"

Author: Milne, George J; Baskaran, Pravin; Halder, Nilimesh; Karl, Stephan; Kelso, Joel
Title: Pandemic influenza in Papua New Guinea: a modelling study comparison with pandemic spread in a developed country
  • Document date: 2013_3_26
  • ID: y01w04lc_289
    Snippet: The present study shows that larger numbers of transmissions occur within households due to the larger household sizes in countries such as PNG. Furthermore, low-income countries generally have population health profiles not seen in developed countries, including the prevalence of diseases such as malaria, tuberculosis and HIV. [49] Antiviral treatment of influenza cases co-infected with such diseases may be an appropriate intervention strategy g.....
    Document: The present study shows that larger numbers of transmissions occur within households due to the larger household sizes in countries such as PNG. Furthermore, low-income countries generally have population health profiles not seen in developed countries, including the prevalence of diseases such as malaria, tuberculosis and HIV. [49] Antiviral treatment of influenza cases co-infected with such diseases may be an appropriate intervention strategy given the poorer health outcomes which co-morbidity may impose. [12] The provision and use of antiviral agents will have challenges not faced by industrialised countries, due to the cost of providing an antiviral stockpile and subsequent distribution of antivirals in countries which have health systems already stretched to capacity. [15] The importance of suitable pandemic influenza preparedness plans for low-income countries is recognized by the WHO [50, 51]. Disease transmission models will play a role in guiding policy makers in determining the effectiveness of possible pandemic countermeasures. History tells us that low-income countries are likely to be more affected, yet almost all models deal with mitigation strategies for developed nations with good health infrastructure and low prevalence of endemic diseases. These countries have poorer access to antiviral drug and vaccine-based interventions and higher extant disease burdens, compared to developed countries. For the reasons, development of appropriate intervention strategies focused on countries such as PNG needs to occur.

    Search related documents:
    Co phrase search for related documents
    • antiviral agent and co morbidity: 1, 2, 3, 4
    • antiviral agent and co morbidity impose: 1, 2, 3, 4
    • antiviral agent and disease burden: 1, 2, 3, 4
    • antiviral drug and appropriate intervention strategy: 1
    • antiviral drug and co morbidity: 1
    • antiviral drug and co morbidity impose: 1
    • antiviral drug and disease burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral stockpile and appropriate intervention strategy: 1, 2, 3, 4
    • antiviral stockpile and co morbidity: 1, 2, 3, 4
    • antiviral stockpile and co morbidity impose: 1, 2, 3, 4
    • antiviral subsequent distribution and appropriate intervention strategy: 1, 2, 3, 4
    • antiviral subsequent distribution and co morbidity: 1, 2, 3, 4
    • antiviral subsequent distribution and co morbidity impose: 1, 2, 3, 4
    • antiviral treatment and appropriate intervention strategy: 1, 2, 3, 4
    • antiviral treatment and co morbidity: 1, 2, 3, 4, 5
    • antiviral treatment and co morbidity impose: 1, 2, 3, 4
    • antiviral treatment and disease burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antiviral treatment and disease infect: 1, 2
    • antiviral treatment and Disease transmission model: 1